Literature DB >> 7971588

Reliability of histological criteria in glycogen storage disease of the liver.

G P Jevon1, M J Finegold.   

Abstract

The histological criteria for the diagnosis of the hepatic glycogen storage diseases (GSDs) are well recognized. However, some biopsies do not have the characteristic features peculiar to their type and not all biopsies with GSD changes are confirmed by enzyme analysis. We reviewed the liver biopsies of 59 patients with clinically suspected GSD. The enzyme defects in 31 of 40 patients with GSD morphology were demonstrated by enzyme analysis. We describe the history and histology of the 9 patients with GSD morphology not confirmed by enzyme analysis, present the diagnoses of the 19 patients shown not to have a GSD, and evaluate the reliability of the morphological criteria used to distinguish the types of hepatic GSD. In this study the predictive value of a biopsy with GSD changes was 90%. Mosaicism, the most sensitive criterion in the diagnosis of GSD, is not type-specific. Fibrosis does not reliably distinguish between the GSD types and although nuclear hyperglycogenation and lipid are characteristic of type I GSD, these features are not diagnostic of any particular enzyme deficiency. The lack of morphological specificity implies that a complete enzyme analysis be performed on each biopsy. A normal enzyme analysis does not exclude a GSD and careful long-term follow-up may be necessary.

Entities:  

Mesh:

Year:  1994        PMID: 7971588     DOI: 10.3109/15513819409023343

Source DB:  PubMed          Journal:  Pediatr Pathol        ISSN: 0277-0938


  2 in total

1.  Glycogen storage disease type Ia: frequency and clinical course in Turkish children.

Authors:  I N Saltik; H Ozen; G Ciliv; N Koçak; A Yüce; F Gürakan; G Dinler
Journal:  Indian J Pediatr       Date:  2000-07       Impact factor: 1.967

2.  Prevalence and clinical profile of glycogen storage diseases in children from Western India.

Authors:  Ira Shah; Drishti Tolani; Naman S Shetty; Vishrutha Karkare
Journal:  Clin Exp Hepatol       Date:  2020-02-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.